TDAC
Translational Development Acquisition Corp. (NASDAQ)
Financial Services — Shell Companies
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
None
$10.67
$-0.02 (-0.19%)
Sign in to add TDAC to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $206.02M |
| P/E Ratio (TTM) | 38.11 |
| Forward P/E | - |
| EPS (TTM) | $0.28 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 27.3 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $10.80 |
| 52-Week Low | $10.28 |
| 50-Day Avg | $10.69 |
| 200-Day Avg | $10.53 |
| Avg Volume | 104.4K |
| Volume | 1 |
Performance Analysis
BULLISHTDAC shows predominantly bullish signals based on its fundamentals and technicals.
+
Showing strength at 75% of its 52-week range.
+
RSI at 27.3 signals oversold conditions — a bounce may be ahead.
~
Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:33 UTC
Back to Screener Export Report